The detailed information for PTAB case with proceeding number PGR2016-00010 filed by Mylan Pharmaceuticals Inc. et al. against Yeda Research and Development Co. Ltd. et al. on Feb 16, 2016. This includes filing dates, application numbers, tech centers, patent numbers, and current case status.

Case Details

Proceeding Number
PGR2016-00010
Filing Date
Feb 16, 2016
Petitioner
Mylan Pharmaceuticals Inc. et al.
Respondent
Yeda Research and Development Co. Ltd. et al.
Status
Institution Denied
Respondent Application Number
14720556
Respondent Tech Center
1600
Respondent Patent Number
9155776
Institution Decision Date
Aug 15, 2016

Proceeding Documents

The table below shows documents filed in the case, listing each document name, filing date, document type, and filing party. Tracking these filings indicates the activity of the parties involved in the case, and the types of documents filed can provide insights into the legal strategies being employed.


Document NameFiling DateCategoryFiling Party

Alert me when new update on this case

Notice of Refund

Oct 18, 2016PAPERBOARD

Refund Request

Oct 14, 2016PAPERPETITIONER

Trial Instituted Document

Aug 15, 2016PAPERBOARD

Patent Owner Yeda Research and Development Co. Ltd.'s Preliminary Response

May 24, 2016PAPERPATENT OWNER

Patent Owner's Exhibit List

May 24, 2016PAPERPATENT OWNER

Patent Owner's Exhibit List

May 24, 2016EXHIBITPATENT OWNER

Declaration of Dr. Edward J. Fox

May 24, 2016EXHIBITPATENT OWNER

U.S. Application No. 61/274,687

May 24, 2016EXHIBITPATENT OWNER

Claim Chart

May 24, 2016EXHIBITPATENT OWNER

U.S. Application No. 13/770,677

May 24, 2016EXHIBITPATENT OWNER

Defendants Initial Joint Invalidity Contentions Regarding U.S. Patent No. 9,155,776

May 24, 2016EXHIBITPATENT OWNER

U.S. Application No. 12/806,684

May 24, 2016EXHIBITPATENT OWNER

U.S. Application No. 61/337,612

May 24, 2016EXHIBITPATENT OWNER

Khan et al., Three Times Weekly Glatiramer Acetate in Relapsing-Remitting Multiple Sclerosis, Ann. Neurol., 2013 73 705713

May 24, 2016EXHIBITPATENT OWNER

Business Wire, Teva Announces Top-Line Results from GALA Phase III Trial Evaluating a New Dosage for Glatiramer Acetate Given Three Times Weekly for Relapsing-Remitting Multiple Sclerosis, June 14, 2012

May 24, 2016EXHIBITPATENT OWNER

Reuters Press Release, New Data Presented at the 28th ECTRIMS Congress Showcase Tevas Ongoing Commitment to Multiple Sclerosis Research, October 8, 2012

May 24, 2016EXHIBITPATENT OWNER

A phase 3 trial to assess the efficacy and safety of glatiramer acetate injections 40 mg administered 3 times a week compared to placebo, Abstract 166, Multiple Sclerosis Journal 2012 18(54) 509-520

May 24, 2016EXHIBITPATENT OWNER

U.S. Application No. 14/630,326

May 24, 2016EXHIBITPATENT OWNER

Cobert, et al., Practical Drug Safety from A to Z, Jones and Bartlett Publishers, 2009, pp. 327-329

May 24, 2016EXHIBITPATENT OWNER

World Health Organization, A Practical Handbook on the Pharmacovigilance of Antiretroviral Medicines, 2009, 129-133

May 24, 2016EXHIBITPATENT OWNER

Power of Attorney

May 18, 2016PAPERPATENT OWNER

Power of Attorney

Mar 8, 2016PAPERINDICATES ARTIFACT WAS SUBMITTED ON BEHALF OF POTENTIAL_PATENT OWNER.

Related Matters

Mar 8, 2016PAPERINDICATES ARTIFACT WAS SUBMITTED ON BEHALF OF POTENTIAL_PATENT OWNER.

Notice of Filing Date Accorded to Petition

Feb 24, 2016PAPERBOARD

Power of Attorney

Feb 16, 2016PAPERPETITIONER

Petition for Post-Grant Review of U.S. Patent No. 9,155,776

Feb 16, 2016PAPERPETITIONER

U.S. Patent No. 9,155,776

Feb 16, 2016EXHIBITPETITIONER

File History for U.S. Patent No. 9,155,776

Feb 16, 2016EXHIBITPETITIONER

Expert Declaration of Dr. Ari Green

Feb 16, 2016EXHIBITPETITIONER

GALA Study Details

Feb 16, 2016EXHIBITPETITIONER

GLACIER Study Details

Feb 16, 2016EXHIBITPETITIONER

Plaintiffs' Supplemental Opening Claim Construction Brief

Feb 16, 2016EXHIBITPETITIONER

U.S. Patent No. 3,849,550

Feb 16, 2016EXHIBITPETITIONER

File History for U.S. Patent No. 8,969,302, Part 1

Feb 16, 2016EXHIBITPETITIONER

File History for U.S. Patent No. 8,969,302, Part 2

Feb 16, 2016EXHIBITPETITIONER

2014 Citizen Petition

Feb 16, 2016EXHIBITPETITIONER

2015 Citizen Petition

Feb 16, 2016EXHIBITPETITIONER

McKeage

Feb 16, 2016EXHIBITPETITIONER

Copaxone Prescribing Information

Feb 16, 2016EXHIBITPETITIONER

Claim Construction Brief

Feb 16, 2016EXHIBITPETITIONER

Plaintiff Claim Construction Brief

Feb 16, 2016EXHIBITPETITIONER

Yeda Preliminary Response in IPR2015-00643

Feb 16, 2016EXHIBITPETITIONER

Deposition of Tjalf Ziemssen

Feb 16, 2016EXHIBITPETITIONER

Comi 2011

Feb 16, 2016EXHIBITPETITIONER

Teva Press Release

Feb 16, 2016EXHIBITPETITIONER

Wolinksy 2014

Feb 16, 2016EXHIBITPETITIONER

Deposition of Edward Fox

Feb 16, 2016EXHIBITPETITIONER

Stipulation

Feb 16, 2016EXHIBITPETITIONER

U.S. Patent No. 8,399,413

Feb 16, 2016EXHIBITPETITIONER

Plaintiff Opening Claim Construction Brief

Feb 16, 2016EXHIBITPETITIONER

Yeda Patent Owner Reponse in IPR2015-00643

Feb 16, 2016EXHIBITPETITIONER

Yeda Patent Owner Response in IPR2015-00644

Feb 16, 2016EXHIBITPETITIONER

Yeda Patent Owner Response in IPR2015-00830

Feb 16, 2016EXHIBITPETITIONER

Miller 2004

Feb 16, 2016EXHIBITPETITIONER

Stewart 2012

Feb 16, 2016EXHIBITPETITIONER

Pelidou 2008

Feb 16, 2016EXHIBITPETITIONER

McEwan 2010

Feb 16, 2016EXHIBITPETITIONER

Singer 2012

Feb 16, 2016EXHIBITPETITIONER

Common Terminology Criteria for Adverse Events

Feb 16, 2016EXHIBITPETITIONER

Frohman 2006

Feb 16, 2016EXHIBITPETITIONER

Haines 1998

Feb 16, 2016EXHIBITPETITIONER

Comi 2001

Feb 16, 2016EXHIBITPETITIONER

Ge 2000

Feb 16, 2016EXHIBITPETITIONER

Soares 2006

Feb 16, 2016EXHIBITPETITIONER

Wolinsky 2015

Feb 16, 2016EXHIBITPETITIONER

Rich 2004

Feb 16, 2016EXHIBITPETITIONER

Bakshi 2005

Feb 16, 2016EXHIBITPETITIONER

Stuart 2004

Feb 16, 2016EXHIBITPETITIONER

Edgar

Feb 16, 2016EXHIBITPETITIONER

Johnson 1995

Feb 16, 2016EXHIBITPETITIONER

Betaseron Label

Feb 16, 2016EXHIBITPETITIONER

Rebif Label

Feb 16, 2016EXHIBITPETITIONER

Avonex Label

Feb 16, 2016EXHIBITPETITIONER

Extavia Label

Feb 16, 2016EXHIBITPETITIONER

Tysabri Label

Feb 16, 2016EXHIBITPETITIONER